TO STUDY THE EFFICACY OF INDIVIDUALISED HOMOEOPATHIC MEDICINE IN PRIMARY DYSMENORRHOEA, COMPARED TO A PLACEBO.

TO STUDY THE EFFICACY OF INDIVIDUALISED HOMOEOPATHIC MEDICINE IN PRIMARY DYSMENORRHOEA: A SINGLE BLIND, RANDOMIZED, PLACEBO CONTROLLED TRIAL. - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085774

Enrollment

Registered

2025-04-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: INDIVIDUALISED HOMOEOPATHIC MEDICINE: INDIVIDUALISED HOMOEOPATHIC MEDICINE WILL BE PRESCRIBED IN SELECTIVE POTENCY AS IN REQUIRED REPETITION FOR 15 DAYS OR WHEN IT IS REQUIRED Control I

Eligibility

Inclusion criteria

Inclusion criteria: 1.Cases with clinical presentation of primary dysmenorrhoea 2.Females of young age group (12-30 years), All socio-economic status 3.Females with regular menstrual cycles 4.Females with no identifiable pathology 5.Patients willing to give informed consent

Exclusion criteria

Exclusion criteria: 1.Female with any pathological conditions like endometriosis, fibroids, pelvic inflammatory disease. 2.Patients who require emergency medical intervention like severe menorrhagia, severe acute pain, pain-induced syncope. 3.Any ongoing homoeopathic or other treatment for dysmenorrhoea. 4.Pregnant or breastfeeding women.

Design outcomes

Primary

Measure	Time frame
1. TO SEE THE EFFICACY OF INDIVIDUALISED HOMOEOPATHIC MEDICINE IN PAIN MANAGEMENT OF PRIMARY DYSMENORRHOEA. 2.TO SEE THE EFFICACY OF PLACEBO IN PAIN MANAGEMENT OF PRIMARY DYSMENORRHOEA. Timepoint: 3 MONTHS	—

Secondary

Measure	Time frame
1.TO ASSESS THE PAIN SEVERITY OF PATIENTS BEFORE AND AFTER IN CASES OF PRIMARY DYSMENORRHOEA USING VISUAL ANALOGUE SCALE (VAS). IMPROVEMENT IF SCORE DECREASE MORE THAN 10 MM FROM BASELINE SCORE 2.TO DETERMINE THE LIST OF MEDICINES AND THE CORRESPONDING POTENCIES FREQUENTLY INDICATED IN THE MANAGEMENT OF PRIMARY DYSMENORRHOEA. Timepoint: 3 MONTHS	—

Countries

India

Contacts

Public ContactDR PARTHA SARTHI MANDAL

JAWAHARLAL NEHRU HOMOEOPATHIC MEDICAL COLLEGE

partha.mandal27317@paruluniversity.ac.in9375095471

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026